Daewoong Strikes New Deal For Botox Rival
This article was originally published in PharmAsia News
Executive Summary
After a past deal with Evolus to sell the product in the U.S. and Europe, Daewoong is searching for other markets in Asia and Latin America for its Botox competitor, and has just linked up with Turkey's Seltek.